CLINICAL RESEARCH
A predictive nomogram for post-acute pancreatitis diabetes mellitus: a retrospective study
More details
Hide details
1
The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, China
2
Department of Laboratory Medicine, Southwest Hospital, Third Military Medical University, Chongqing, China
These authors had equal contribution to this work
Submission date: 2023-09-23
Final revision date: 2023-11-14
Acceptance date: 2023-11-26
Online publication date: 2024-08-21
Corresponding author
Gang Luo
The Affiliated Hospital of Southwest Medical University, China
Arch Med Sci 2025;21(2)
KEYWORDS
TOPICS
ABSTRACT
Introduction:
Post-acute pancreatitis diabetes mellitus (PPDM-A) is a non-negligible sequela of acute pancreatitis (AP), as it has a greater risk of mortality and development of pancreatic cancer compared to type 2 diabetes mellitus (T2DM). Early screening and diagnosis after the onset of pancreatitis are crucial for the outcome of patients. We aimed to establish a predictive nomogram for PPDM-A for early screening and identification.
Material and methods:
A total of 130 patients diagnosed with PPDM-A and 260 gender-matched non-diabetic AP (non-PPDM-A) patients were retrospectively included in this study. They were assigned to a training cohort and a validation cohort with a ratio of 7:3. General information and essential clinical indicators were collected. The Chinese visceral fat index (CVAI) was calculated. Multiple logistic regression was applied to analyze the risk factors of PPDM-A in the training cohort and a predictive model was built. This model was verified in a validation cohort.
Results:
CVAI, admission blood glucose value (GLU), blood amylase (AMY), recurrent acute pancreatitis (RAP), moderately severe acute pancreatitis (MSAP), and severe acute pancreatitis/critical acute pancreatitis (SAP/CAPA) are risk factors for PPDM-A. The area under the curve (AUC) of the prediction model was 0.917. When the cut-off value was 0.356, the sensitivity was 0.888, the specificity was 0.809, and the k was 0.679. The Hosmer-Lemeshow Hosmer test showed a good fit.
Conclusions:
CVAI, GLU, AMY, RAP, and severity of AP are risk factors for PPDM-A. The predictive nomogram established in this study can effectively predict the occurrence of PPDM-A.
REFERENCES (29)
1.
Xiao AY, Tan ML, Wu LM, et al. Global incidence and mortality of pancreatic diseases: a systematic review, meta-analysis, and meta-regression of population-based cohort studies. Lancet Gastroenterol Hepatol 2016; 1: 45-55.
2.
Cho J, Petrov MS. Pancreatitis, pancreatic cancer, and their metabolic sequelae: projected burden to 2050. Clin Transl Gastroenterol 2020; 11: e00251.
3.
Jaber S, Garnier M, Asehnoune K, et al. Guidelines for the management of patients with severe acute pancreatitis, 2021. Anaesth Crit Care Pain Med 2022; 41: 101060.
4.
van den Berg FF, Boermeester MA. Update on the management of acute pancreatitis. Curr Opin Crit Care 2023; 29: 145-51.
5.
Yu B, Li J, Li N, et al. Progression to recurrent acute pancreatitis after a first attack of acute pancreatitis in adults. Pancreatology 2020; 20: 1340-6.
6.
Huang W, de la Iglesia-García D, Baston-Rey I, et al. Exocrine pancreatic insufficiency following acute pancreatitis: systematic review and meta-analysis. Dig Dis Sci 2019; 64: 1985-2005.
7.
Das SL, Singh PP, Phillips AR, Murphy R, Windsor JA, Petrov MS. Newly diagnosed diabetes mellitus after acute pancreatitis: a systematic review and meta-analysis. Gut 2014; 63: 818-31.
8.
ElSayed NA, Aleppo G, Aroda VR, et al. Erratum. 2. Classification and diagnosis of diabetes: standards of care in diabetes-2023. Diabetes Care 2023; 46 (Suppl. 1): S19-40. Diabetes Care 2023; 46: 1106.
9.
Hart PA, Bellin MD, Andersen DK, et al. Type 3c (pancreatogenic) diabetes mellitus secondary to chronic pancreatitis and pancreatic cancer. Lancet Gastroenterol Hepatol 2016; 1: 226-37.
10.
Petrov MS. Panorama of mediators in postpancreatitis diabetes mellitus. Curr Opin Gastroenterol 2020; 36: 443-51.
11.
Olesen SS, Svane HML, Nicolaisen SK, et al. Clinical and biochemical characteristics of postpancreatitis diabetes mellitus: a cross-sectional study from the Danish nationwide DD2 cohort. J Diabetes 2021; 13: 960-74.
12.
Cho J, Scragg R, Petrov MS. Postpancreatitis diabetes confers higher risk for pancreatic cancer than type 2 diabetes: results from a Nationwide Cancer Registry. Diabetes Care 2020; 43: 2106-12.
13.
Zhang J, Lv Y, Hou J, et al. Machine learning for post-acute pancreatitis diabetes mellitus prediction and personalized treatment recommendations. Sci Rep 2023; 13: 4857.
14.
Sternby H, Bolado F, Canaval-Zuleta HJ, et al. Determinants of severity in acute pancreatitis: a nation-wide multicenter prospective cohort study. Ann Surg 2019; 270: 348-55.
15.
Xia MF, Chen Y, Lin HD, et al. A indicator of visceral adipose dysfunction to evaluate metabolic health in adult Chinese. Sci Rep 2016; 6: 38214.
16.
Petrov MS, Taylor R. Intra-pancreatic fat deposition: bringing hidden fat to the fore. Nat Rev Gastroenterol Hepatol 2022; 19: 153-68.
17.
Ren Y, Cheng L, Qie R, et al. Dose-response association of Chinese visceral adiposity index with comorbidity of hypertension and diabetes mellitus among elderly people. Front Endocrinol (Lausanne) 2023; 14: 1187381.
18.
Feng X, Wang J, Wang S, et al. Correlation analysis of anthropometric indices and type 2 diabetes mellitus in residents aged 60 years and older. Front Public Health 2023; 11: 1122509.
19.
Tang M, Wei XH, Cao H, et al. Association between Chinese visceral adiposity index and metabolic-associated fatty liver disease in Chinese adults with type 2 diabetes mellitus. Front Endocrinol (Lausanne) 2022; 13: 935980.
20.
Pan L, Gao Y, Han J, et al. Comparison of longitudinal changes in four surrogate insulin resistance indexes for incident T2DM in middle-aged and elderly Chinese. Front Public Health 2022; 10: 1046223.
21.
Han M, Qin P, Li Q, et al. Chinese visceral adiposity index: a reliable indicator of visceral fat function associated with risk of type 2 diabetes. Diabetes Metab Res Rev 2021; 37: e3370.
22.
Olesen SS, Krarup H, Poulsen JL, et al. Pancreas-specific plasma amylase for assessment and diagnosis of chronic pancreatitis: new insights on an old topic. United European Gastroenterol J 2019; 7: 955-64.
23.
Tu J, Yang Y, Zhang J, et al. Effect of the disease severity on the risk of developing new-onset diabetes after acute pancreatitis. Medicine (Baltimore) 2018; 97: e10713.
24.
Xiao B, Xu HB, Jiang ZQ, Hu JX, Yang GD. Acute pancreatitis in patients with a medical history of type 2 diabetes mellitus: clinical findings and magnetic resonance imaging characteristics. Pancreas 2020; 49: 591-7.
25.
Vipperla K, Papachristou GI, Slivka A, Whitcomb DC, Yadav D. Risk of new-onset diabetes is determined by severity of acute pancreatitis. Pancreas 2016; 45: e14-5.
26.
Walker A, O’Kelly J, Graham C, Nowell S, Kidd D, Mole DJ. Increased risk of type 3c diabetes mellitus after acute pancreatitis warrants a personalized approach including diabetes screening. BJS Open 2022; 6: zrac148.
27.
Avanesov M, Löser A, Smagarynska A, et al. Clinico-radiological comparison and short-term prognosis of single acute pancreatitis and recurrent acute pancreatitis including pancreatic volumetry. PLoS One 2018; 13: e0206062.
28.
Tu J, Zhang J, Ke L, et al. Endocrine and exocrine pancreatic insufficiency after acute pancreatitis: long-term follow-up study. BMC Gastroenterol 2017; 17: 114.
29.
Zhi M, Zhu X, Lugea A, Waldron RT, Pandol SJ, Li L. Incidence of new onset diabetes mellitus secondary to acute pancreatitis: a systematic review and meta-analysis. Front Physiol 2019; 10: 637.